These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 22300406)

  • 21. Mitochondrial dysfunction: the missing link between aging and sporadic Alzheimer's disease.
    Grimm A; Friedland K; Eckert A
    Biogerontology; 2016 Apr; 17(2):281-96. PubMed ID: 26468143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Wnt signaling in Alzheimer's disease: up or down, that is the question.
    Boonen RA; van Tijn P; Zivkovic D
    Ageing Res Rev; 2009 Apr; 8(2):71-82. PubMed ID: 19101658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The human β-amyloid precursor protein: biomolecular and epigenetic aspects.
    Nguyen KV
    Biomol Concepts; 2015 Mar; 6(1):11-32. PubMed ID: 25719338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The antimicrobial protection hypothesis of Alzheimer's disease.
    Moir RD; Lathe R; Tanzi RE
    Alzheimers Dement; 2018 Dec; 14(12):1602-1614. PubMed ID: 30314800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alzheimer's Disease Prevention and Treatment: Case for Optimism.
    Volloch V; Olsen B; Rits S
    Ann Integr Mol Med; 2020; 2(1):115-130. PubMed ID: 33043322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular genetics of familial Alzheimer's disease.
    Schellenberg GD
    Arzneimittelforschung; 1995 Mar; 45(3A):418-24. PubMed ID: 7763337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholesterol and Alzheimer's disease: clinical and experimental models suggest interactions of different genetic, dietary and environmental risk factors.
    Sambamurti K; Granholm AC; Kindy MS; Bhat NR; Greig NH; Lahiri DK; Mintzer JE
    Curr Drug Targets; 2004 Aug; 5(6):517-28. PubMed ID: 15270198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paradigm shift redefining molecular, metabolic and structural events in Alzheimer's disease involves a proposed contribution by transition metals. Defined lengthy preclinical stage provides new hope to circumvent advancement of disease- and age-related neurodegeneration.
    Cavaleri F
    Med Hypotheses; 2015 May; 84(5):460-9. PubMed ID: 25691377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early-life stress lastingly alters the neuroinflammatory response to amyloid pathology in an Alzheimer's disease mouse model.
    Hoeijmakers L; Ruigrok SR; Amelianchik A; Ivan D; van Dam AM; Lucassen PJ; Korosi A
    Brain Behav Immun; 2017 Jul; 63():160-175. PubMed ID: 28027926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered CpG methylation in sporadic Alzheimer's disease is associated with APP and MAPT dysregulation.
    Iwata A; Nagata K; Hatsuta H; Takuma H; Bundo M; Iwamoto K; Tamaoka A; Murayama S; Saido T; Tsuji S
    Hum Mol Genet; 2014 Feb; 23(3):648-56. PubMed ID: 24101602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deposition of C-terminally truncated Aβ species Aβ37 and Aβ39 in Alzheimer's disease and transgenic mouse models.
    Reinert J; Richard BC; Klafki HW; Friedrich B; Bayer TA; Wiltfang J; Kovacs GG; Ingelsson M; Lannfelt L; Paetau A; Bergquist J; Wirths O
    Acta Neuropathol Commun; 2016 Mar; 4():24. PubMed ID: 26955942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modeling Alzheimer's disease in transgenic mice: effect of age and of presenilin1 on amyloid biochemistry and pathology in APP/London mice.
    Dewachter I; van Dorpe J; Spittaels K; Tesseur I; Van Den Haute C; Moechars D; Van Leuven F
    Exp Gerontol; 2000 Sep; 35(6-7):831-41. PubMed ID: 11053674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lithium may be useful in the prevention of Alzheimer's disease in individuals at risk of presenile familial Alzheimer's disease.
    Yeh HL; Tsai SJ
    Med Hypotheses; 2008 Dec; 71(6):948-51. PubMed ID: 18760542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Omega-3 fatty acid docosahexaenoic acid increases SorLA/LR11, a sorting protein with reduced expression in sporadic Alzheimer's disease (AD): relevance to AD prevention.
    Ma QL; Teter B; Ubeda OJ; Morihara T; Dhoot D; Nyby MD; Tuck ML; Frautschy SA; Cole GM
    J Neurosci; 2007 Dec; 27(52):14299-307. PubMed ID: 18160637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Familial Alzheimer's disease: genetic influences on the disease process (Review).
    Lippa CF
    Int J Mol Med; 1999 Nov; 4(5):529-36. PubMed ID: 10534576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of Synaptic Amyloid-β Generation through BACE1 Retrograde Transport in a Mouse Model of Alzheimer's Disease.
    Ye X; Feng T; Tammineni P; Chang Q; Jeong YY; Margolis DJ; Cai H; Kusnecov A; Cai Q
    J Neurosci; 2017 Mar; 37(10):2639-2655. PubMed ID: 28159908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Presenilins and Alzheimer's disease: biological functions and pathogenic mechanisms.
    Czech C; Tremp G; Pradier L
    Prog Neurobiol; 2000 Mar; 60(4):363-84. PubMed ID: 10670705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aging, cortical injury and Alzheimer's disease-like pathology in the guinea pig brain.
    Bates K; Vink R; Martins R; Harvey A
    Neurobiol Aging; 2014 Jun; 35(6):1345-51. PubMed ID: 24360504
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.